L-quinurenina, mín. 98 %, para bioquímica, 250 mg, envase de vidrio

4-(4-Iodo-1H-pyrazol-1-yl)benzonitrile, 97%, 100mg

1-[2-(2-thienyl)-1,3-thiazol-4-yl]methanamine, 95.0%, 100mg

3-(1-naphthyl)-1{H}-pyrazole-5-carboxylic acid, 95.0%, 1g

4-Chlorobenzenesulfonyl fluoride, 95%, 5g

2-Amino-1-(4-(trifluoromethyl)phenyl)ethanonehydrochloride, 95.0%, 250mg

2-(4-n-Butylbenzoyl)pyridine, 97.0%, 1g

4-Bromo-2,3,5,6-tetrafluorobenzotrifluoride, 97.0%, 1g

4-((tert-Butoxycarbonyl)amino)-2-phenylbutanoic acid, 95.0%, 1g

4-(Chloromethyl)benzoyl Chloride>98.0%(GC)(T)100g

3-(2-Bromo-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)piperidine-2,6-dione, 98%, 1g

2-Chloro-N-isoxazolo[5,4-b]pyridin-3-yl-acetamide, 95.0%, 500mg

5-Amino-3-methyl-1H-pyrazole-4-carboxylic acid ethyl ester, 97.0%, 5g